Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 78055

7 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 14, 2017
Product types
Device
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Leica Biosystems Richmond Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

7 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 7

Cell Marque, Podoplanin (D2-40 Mab), 7 mL, REF PA0796, IVD, The antibody is intended for in vitro diagnostic (IVD) use. The Podoplanin (D2-40) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods

Z-3120-2017
Recall number
Z-3120-2017
Initiated
July 14, 2017
Classification
Class II
Status
Terminated
Quantity
4

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Storage

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

Code information

Product Code PA0796, Lot No. 47793, Exp. Date 09/24/2019

Distribution pattern

Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.

device · product 2 of 7

Cell Marque, Glypican-3 (1G12 Mab), 7 mL, REF PA0800, IVD, The antibody is intended for in vitro diagnostic (IVD) use. Glypican-3 (1G12) Mouse Monoclonal Primary Antibody is intended for laboratory use in the detection of the Glypican-3 protein in formalin-fixed, paraffin-embedded tissue stained in qualitative immunohistochemistry (IHC) testing.

Z-3121-2017
Recall number
Z-3121-2017
Initiated
July 14, 2017
Classification
Class II
Status
Terminated
Quantity
3

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Storage

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

Code information

Product Code PA0800, Lot No. 46232, Exp. Date 06/04/2019

Distribution pattern

Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.

device · product 3 of 7

Cell Marque, Microphthalmia Transcription Factor (MiTF) (C5/D5 Mab.), 7 mL, REF PA0803, IVD, The antibody is intended for in vitro diagnostic (IVD) use. The Microphthalmia Transcription Factor (MiTF) (C5/D5) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods.

Z-3122-2017
Recall number
Z-3122-2017
Initiated
July 14, 2017
Classification
Class II
Status
Terminated
Quantity
10

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Storage

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

Code information

Product Code PA0803, Lot No. 46524, Exp. Date 06/25/2019

Distribution pattern

Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.

device · product 4 of 7

Cell Marque, MSH6 (44 Mab.), 7 mL, REF PA0804, IVD, The antibody is intended for in vitro diagnostic (IVD) use. MSH6 is a mismatch repair gene which is deficient in a high proportion of patients with microsatellite instability (MSI-H). This finding is associated with the autosomal dominant condition known as Hereditary Non-Polyposis Colon Cancer (HNPCC).

Z-3123-2017
Recall number
Z-3123-2017
Initiated
July 14, 2017
Classification
Class II
Status
Terminated
Quantity
13

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Storage

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

Code information

Product Code PA0804, Lot No. 45973, Exp. Date 05/21/2019

Distribution pattern

Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.

device · product 5 of 7

Cell Marque, Napsin A (MRQ-60 Mab.), 7 mL, REF PA0805, IVD, The antibody is intended for in vitro diagnostic (IVD) use. Napsin A (MRQ-60) Mouse Monoclonal Primary Antibody is intended for laboratory use in the detection of the Napsin A protein in formalin-fixed, paraffin-embedded tissue stained in qualitative immunohistochemistry (IHC) testing.

Z-3124-2017
Recall number
Z-3124-2017
Initiated
July 14, 2017
Classification
Class II
Status
Terminated
Quantity
33

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Storage

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

Code information

Product Code PA0805, Lot No. 46349, Exp. Date 06/11/2019

Distribution pattern

Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.

device · product 6 of 7

Cell Marque, PAX8 (MRQ-50 Mab.), 7 mL, REF PA0808, IVD, This antibody is intended for in vitro diagnostic (IVD) use. PAX-8 (MRQ-50) Mouse Monoclonal Primary Antibody is intended for laboratory use in the detection of the PAX-8 protein in formalin-fixed, paraffin-embedded tissue stained in qualitative immunohistochemistry (IHC) testing

Z-3125-2017
Recall number
Z-3125-2017
Initiated
July 14, 2017
Classification
Class II
Status
Terminated
Quantity
5

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Storage

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

Code information

Product Code PA0808, Lot No. 47795, Exp. Date 09/24/2019

Distribution pattern

Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.

device · product 7 of 7

Cell Marque, SOX-10 (Polyclonal), 7 mL, REF PA0813, IVD, This antibody is intended for in vitro diagnostic (IVD) use. SOX-10 Rabbit Polyclonal Primary Antibody is intended for laboratory use in the detection of the SOX-10 protein in formalin-fixed, paraffin-embedded tissue stained in qualitative immunohistochemistry (IHC) testing..

Z-3126-2017
Recall number
Z-3126-2017
Initiated
July 14, 2017
Classification
Class II
Status
Terminated
Quantity
37

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Storage

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

Code information

Product Code PA0813, Lot No. 47800, Exp. Date 09/24/2019

Distribution pattern

Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.